The histone LSD1 demethylase in stemness and cancer transcription programs

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1829, Issue 10, 2013, Pages 981-986

  Amente, Stefano ^a   Lania, Luigi ^a   Majello, Barbara ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cancer; Chromatin; Histone modification; LSD1; Stem cell

Indexed keywords

DNA; HISTONE DEMETHYLASE; KRUPPEL LIKE FACTOR 4; LYSINE SPECIFIC DEMETHYLASE 1; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; APOPTOSIS; BLADDER CANCER; CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL STRUCTURE; CHROMATIN ASSEMBLY AND DISASSEMBLY; DEACETYLATION; DNA SEQUENCE; EMBRYO DEVELOPMENT; EMBRYONAL CARCINOMA; EMBRYONIC STEM CELL; ENZYME ACTIVITY; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; HISTONE ACETYLATION; HISTONE MODIFICATION; IMMUNOPHENOTYPING; LEUKEMIA CELL; LEUKEMOGENESIS; LIVER CELL CARCINOMA; LUNG CANCER; MOLECULAR MECHANICS; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SEMINOMA; SOLID TUMOR; STEM CELL; T CELL LEUKEMIA; TERATOMA;

CANCER; CHROMATIN; HISTONE MODIFICATION; LSD1; STEM CELL;

CHROMATIN; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEMETHYLASES; HUMANS; NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 84880719085     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2013.05.002     Document Type: Review

References (77)

1. Young R.A. Control of the embryonic stem cell state. Cell 2011, 144:940-954.
2. Orkin S.H., Hochedlinger K. Chromatin connections to pluripotency and cellular reprogramming. Cell 2011, 145:835-850.
3. Dawson M.A., Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 2012, 150:12-27.
4. Hu Q., Rosenfeld M.G. Epigenetic regulation of human embryonic stem cells. Front. Genet. 2012, 3:238.
5. Black J.C., Van Rechem C., Whetstine J.R. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol. Cell 2012, 48:491-507.
6. Greer E.L., Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 2012, 13:343-357.
7. Sharma S., Kelly T.K., Jones P.A. Epigenetics in cancer. Carcinogenesis 2010, 31:27-36.
8. Rotili D., Mai A. Targeting histone demethylases: a new avenue for the fight against cancer. Genes Cancer 2011, 2:663-679.
9. Shi Y. Histone lysine demethylases: emerging roles in development, physiology and disease. Nat. Rev. Genet. 2007, 8:829-833.
10. Lynch J.T., Harris W.J., Somervaille T.C. LSD1 inhibition: a therapeutic strategy in cancer?. Expert Opin. Ther. Targets 2012, 16:1239-1249.
11. Cohen I., Poreba E., Kamieniarz K., Schneider R. Histone modifiers in cancer: friends or foes?. Genes Cancer 2011, 2:631-647.
12. Humphrey G.W., Wang Y., Russanova V.R., Hirai T., Qin J., Nakatani Y., Howard B.H. Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J. Biol. Chem. 2001, 276:6817-6824.
13. Shi Y., Sawada J., Sui G., Affar el B., Whetstine J.R., Lan F., Ogawa H., Luke M.P., Nakatani Y. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 2003, 422:735-738.
14. Shi Y., Lan F., Matson C., Mulligan P., Whetstine J.R., Cole P.A., Casero R.A. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004, 119:941-953.
15. Karytinos A., Forneris F., Profumo A., Ciossani G., Battaglioli E., Binda C., Mattevi A. A novel mammalian flavin-dependent histone demethylase. J. Biol. Chem. 2009, 284:17775-17782.
16. Opel M., Lando D., Bonilla C., Trewick S.C., Boukaba A., Walfridsson J., Cauwood J., Werler P.J., Carr A.M., Kouzarides T., Murzina N.V., Allshire R.C., Ekwall K., Laue E.D. Genome-wide studies of histone demethylation catalysed by the fission yeast homologues of mammalian LSD1. PLoS One 2007, 2:e386.
17. Rudolph T., Yonezawa M., Lein S., Heidrich K., Kubicek S., Schafer C., Phalke S., Walther M., Schmidt A., Jenuwein T., Reuter G. Heterochromatin formation in Drosophila is initiated through active removal of H3K4 methylation by the LSD1 homolog SU(VAR)3-3. Mol. Cell 2007, 26:103-115.
18. Forneris F., Binda C., Vanoni M.A., Mattevi A., Battaglioli E. Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process. FEBS Lett. 2005, 579:2203-2207.
19. Forneris F., Binda C., Battaglioli E., Mattevi A. LSD1: oxidative chemistry for multifaceted functions in chromatin regulation. Trends Biochem. Sci. 2008, 33:181-189.
20. Lan F., Nottke A.C., Shi Y. Mechanisms involved in the regulation of histone lysine demethylases. Curr. Opin. Cell Biol. 2008, 20:316-325.
21. Forneris F., Binda C., Vanoni M.A., Battaglioli E., Mattevi A. Human histone demethylase LSD1 reads the histone code. J. Biol. Chem. 2005, 280:41360-41365.
22. Chen Y., Yang Y., Wang F., Wan K., Yamane K., Zhang Y., Lei M. Crystal structure of human histone lysine-specific demethylase 1 (LSD1). Proc. Natl. Acad. Sci. U. S. A. 2006, 103:13956-13961.
23. Lee M.G., Wynder C., Schmidt D.M., McCafferty D.G., Shiekhattar R. Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem. Biol. 2006, 13:563-567.
24. Binda C., Valente S., Romanenghi M., Pilotto S., Cirilli R., Karytinos A., Ciossani G., Botrugno O.A., Forneris F., Tardugno M., Edmondson D.E., Minucci S., Mattevi A., Mai A. Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2. J. Am. Chem. Soc. 2010, 132:6827-6833.
25. Culhane J.C., Wang D., Yen P.M., Cole P.A. Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors. J. Am. Chem. Soc. 2010, 132.
26. Metzger E., Wissmann M., Yin N., Muller J.M., Schneider R., Peters A.H., Gunther T., Buettner R., Schule R. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005, 437:436-439.
27. Wissmann M., Yin N., Muller J.M., Greschik H., Fodor B.D., Jenuwein T., Vogler C., Schneider R., Gunther T., Buettner R., Metzger E., Schule R. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat. Cell Biol. 2007, 9:347-353.
28. Perillo B., Ombra M.N., Bertoni A., Cuozzo C., Sacchetti S., Sasso A., Chiariotti L., Malorni A., Abbondanza C., Avvedimento E.V. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 2008, 319:202-206.
29. Garcia-Bassets I., Kwon Y.S., Telese F., Prefontaine G.G., Hutt K.R., Cheng C.S., Ju B.G., Ohgi K.A., Wang J., Escoubet-Lozach L., Rose D.W., Glass C.K., Fu X.D., Rosenfeld M.G. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 2007, 128:505-518.
30. Metzger E., Imhof A., Patel D., Kahl P., Hoffmeyer K., Friedrichs N., Muller J.M., Greschik H., Kirfel J., Ji S., Kunowska N., Beisenherz-Huss C., Gunther T., Buettner R., Schule R. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4. Nature 2010, 464:792-796.
31. Nair S.S., Nair B.C., Cortez V., Chakravarty D., Metzger E., Schule R., Brann D.W., Tekmal R.R., Vadlamudi R.K. PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor-alpha target gene activation by regulating lysine demethylase 1 specificity. EMBO Rep. 2010, 11:438-444.
32. Amente S., Bertoni A., Morano A., Lania L., Avvedimento E.V., Majello B. LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription. Oncogene 2010, 29:3691-3702.
33. Amente S., Lania L., Avvedimento E.V., Majello B. DNA oxidation drives Myc mediated transcription. Cell Cycle 2010, 9:3002-3004.
34. Biswas D., Milne T.A., Basrur V., Kim J., Elenitoba-Johnson K.S., Allis C.D., Roeder R.G. Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:15751-15756.
35. Nakamura T., Mori T., Tada S., Krajewski W., Rozovskaia T., Wassell R., Dubois G., Mazo A., Croce C.M., Canaani E. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol. Cell 2002, 10:1119-1128.
36. Huang J., Sengupta R., Espejo A.B., Lee M.G., Dorsey J.A., Richter M., Opravil S., Shiekhattar R., Bedford M.T., Jenuwein T., Berger S.L. p53 is regulated by the lysine demethylase LSD1. Nature 2007, 449:105-108.
37. Scoumanne A., Chen X. The lysine-specific demethylase 1 is required for cell proliferation in both p53-dependent and -independent manners. J. Biol. Chem. 2007, 282:15471-15475.
38. Kontaki H., Talianidis I. Cross-talk between post-translational modifications regulate life or death decisions by E2F1. Cell Cycle 2010, 9:3836-3837.
39. Kontaki H., Talianidis I. Lysine methylation regulates E2F1-induced cell death. Mol. Cell 2010, 39:152-160.
40. Cho H.S., Suzuki T., Dohmae N., Hayami S., Unoki M., Yoshimatsu M., Toyokawa G., Takawa M., Chen T., Kurash J.K., Field H.I., Ponder B.A., Nakamura Y., Hamamoto R. Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells. Cancer Res. 2011, 71:655-660.
41. Wang J., Hevi S., Kurash J.K., Lei H., Gay F., Bajko J., Su H., Sun W., Chang H., Xu G., Gaudet F., Li E., Chen T. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat. Genet. 2009, 41:125-129.
42. Foster C.T., Dovey O.M., Lezina L., Luo J.L., Gant T.W., Barlev N., Bradley A., Cowley S.M. Lysine-specific demethylase 1 regulates the embryonic transcriptome and CoREST stability. Mol. Cell. Biol. 2010, 30:4851-4863.
43. Di Stefano L., Ji J.Y., Moon N.S., Herr A., Dyson N. Mutation of Drosophila Lsd1 disrupts H3-K4 methylation, resulting in tissue-specific defects during development. Curr. Biol. 2007, 17:808-812.
44. Katz D.J., Edwards T.M., Reinke V., Kelly W.G. A C. elegans LSD1 demethylase contributes to germline immortality by reprogramming epigenetic memory. Cell 2009, 137:308-320.
45. Wang J., Scully K., Zhu X., Cai L., Zhang J., Prefontaine G.G., Krones A., Ohgi K.A., Zhu P., Garcia-Bassets I., Liu F., Taylor H., Lozach J., Jayes F.L., Korach K.S., Glass C.K., Fu X.D., Rosenfeld M.G. Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature 2007, 446:882-887.
46. Musri M.M., Carmona C., Hanzu F.A., Kaliman P., Gomis R., Parrizas M. Histone demethylase LSD1 regulates adipogenesis. J. Biol. Chem. 2010, 285:30034-30041.
47. Choi J., Jang H., Kim H., Kim S.T., Cho E.J., Youn H.D. Histone demethylase LSD1 is required to induce skeletal muscle differentiation by regulating myogenic factors. Biochem. Biophys. Res. Commun. 2010, 401:327-332.
48. McDonald O.G., Wu H., Timp W., Doi A., Feinberg A.P. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat. Struct. Mol. Biol. 2011, 18:867-874.
49. Lin T., Ponn A., Hu X., Law B.K., Lu J. Requirement of the histone demethylase LSD1 in Snail1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene 2010, 29:4896-4904.
50. Kim J., Orkin S.H. Embryonic stem cell-specific signatures in cancer: insights into genomic regulatory networks and implications for medicine. Genome Med. 2011, 3:75.
51. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., Guenther M.G., Kumar R.M., Murray H.L., Jenner R.G., Gifford D.K., Melton D.A., Jaenisch R., Young R.A. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
52. Chen X., Xu H., Yuan P., Fang F., Huss M., Vega V.B., Wong E., Orlov Y.L., Zhang W., Jiang J., Loh Y.H., Yeo H.C., Yeo Z.X., Narang V., Govindarajan K.R., Leong B., Shahab A., Ruan Y., Bourque G., Sung W.K., Clarke N.D., Wei C.L., Ng H.H. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133:1106-1117.
53. Kim J., Chu J., Shen X., Wang J., Orkin S.H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008, 132:1049-1061.
54. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., Bourque G., George J., Leong B., Liu J., Wong K.Y., Sung K.W., Lee C.W., Zhao X.D., Chiu K.P., Lipovich L., Kuznetsov V.A., Robson P., Stanton L.W., Wei C.L., Ruan Y., Lim B., Ng H.H. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 2006, 38:431-440.
55. Marson A., Levine S.S., Cole M.F., Frampton G.M., Brambrink T., Johnstone S., Guenther M.G., Johnston W.K., Wernig M., Newman J., Calabrese J.M., Dennis L.M., Volkert T.L., Gupta S., Love J., Hannett N., Sharp P.A., Bartel D.P., Jaenisch R., Young R.A. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 2008, 134:521-533.
56. Niwa H., Burdon T., Chambers I., Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 1998, 12:2048-2060.
57. Sato N., Meijer L., Skaltsounis L., Greengard P., Brivanlou A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 2004, 10:55-63.
58. Adamo A., Barrero M.J., Izpisua Belmonte J.C. LSD1 and pluripotency: a new player in the network. Cell Cycle 2011, 10:3215-3216.
59. Adamo A., Sese B., Boue S., Castano J., Paramonov I., Barrero M.J., Izpisua Belmonte J.C. LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells. Nat. Cell Biol. 2011, 13:652-659.
60. Whyte W.A., Bilodeau S., Orlando D.A., Hoke H.A., Frampton G.M., Foster C.T., Cowley S.M., Young R.A. Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature 2012, 482:221-225.
61. Cartwright P., McLean C., Sheppard A., Rivett D., Jones K., Dalton S. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 2005, 132:885-896.
62. Varlakhanova N.V., Cotterman R.F., deVries W.N., Morgan J., Donahue L.R., Murray S., Knowles B.B., Knoepfler P.S. myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation 2010, 80:9-19.
63. Neri F., Zippo A., Krepelova A., Cherubini A., Rocchigiani M., Oliviero S. Myc regulates the transcription of the PRC2 gene to control the expression of developmental genes in embryonic stem cells. Mol. Cell. Biol. 2012, 32:840-851.
64. Kahl P., Gullotti L., Heukamp L.C., Wolf S., Friedrichs N., Vorreuther R., Solleder G., Bastian P.J., Ellinger J., Metzger E., Schule R., Buettner R. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res. 2006, 66:11341-11347.
65. Kauffman E.C., Robinson B.D., Downes M.J., Powell L.G., Lee M.M., Scherr D.S., Gudas L.J., Mongan N.P. Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol. Carcinog. 2011, 50:931-944.
66. Schulte J.H., Lim S., Schramm A., Friedrichs N., Koster J., Versteeg R., Ora I., Pajtler K., Klein-Hitpass L., Kuhfittig-Kulle S., Metzger E., Schule R., Eggert A., Buettner R., Kirfel J. Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Cancer Res. 2009, 69:2065-2071.
67. Lv T., Yuan D., Miao X., Lv Y., Zhan P., Shen X., Song Y. Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer. PLoS One 2012, 7:e35065.
68. Zhao Z.K., Dong P., Gu J., Chen L., Zhuang M., Lu W.J., Wang D.R., Liu Y.B. Overexpression of LSD1 in hepatocellular carcinoma: a latent target for the diagnosis and therapy of hepatoma. Tumour Biol. 2012.
69. Hayami S., Kelly J.D., Cho H.S., Yoshimatsu M., Unoki M., Tsunoda T., Field H.I., Neal D.E., Yamaue H., Ponder B.A., Nakamura Y., Hamamoto R. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int. J. Cancer 2011, 128:574-586.
70. Harris W.J., Huang X., Lynch J.T., Spencer G.J., Hitchin J.R., Li Y., Ciceri F., Blaser J.G., Greystoke B.F., Jordan A.M., Miller C.J., Ogilvie D.J., Somervaille T.C. The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. Cancer Cell 2012, 21:473-487.
71. Schenk T., Chen W.C., Gollner S., Howell L., Jin L., Hebestreit K., Klein H.U., Popescu A.C., Burnett A., Mills K., Casero R.A., Marton L., Woster P., Minden M.D., Dugas M., Wang J.C., Dick J.E., Muller-Tidow C., Petrie K., Zelent A. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat. Med. 2012, 18:605-611.
72. Vu L.P., Luciani L., Nimer S.D. Histone-modifying enzymes: their role in the pathogenesis of acute leukemia and their therapeutic potential. Int. J. Hematol. 2013.
73. Lokken A.A., Zeleznik-Le N.J. Breaking the LSD1/KDM1A addiction: therapeutic targeting of the epigenetic modifier in AML. Cancer Cell 2012, 21:451-453.
74. Lobry C., Oh P., Aifantis I. Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think. J. Exp. Med. 2011, 208:1931-1935.
75. Yatim A., Benne C., Sobhian B., Laurent-Chabalier S., Deas O., Judde J.G., Lelievre J.D., Levy Y., Benkirane M. NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. Mol. Cell 2012, 48:445-458.
76. Hu X., Li X., Valverde K., Fu X., Noguchi C., Qiu Y., Huang S. LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proc. Natl. Acad. Sci. USA 2009, 106:10141-10146.
77. Li Y., Deng C., Hu X., Patel B., Fu X., Qiu Y., Brand M., Zhao K., Huang S. Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis. Oncogene 2012, 31:5007-5018.